Antibodies to delta sleep-inducing peptide in ultralow doses: study of the effect by enzyme immunoassay.
Myagkova. M A MA; Abramenko. T V TV; Panchenko. O N ON; Epstein. O I OI
Key Findings
- Antibodies to DSIP were prepared in very high dilutions (C3, C6, C12, C50, C200).
- Enzyme immunoassay detected immune‑complex formation from these antibodies at dilutions between 1:400 and 1:3200.
- The authors suggest the assay could help identify ultralow‑dose medicinal preparations.
Practical Outcomes
- There are no actionable dosing guidelines or performance benefits presented. The study is purely methodological, so biohackers cannot apply it to real‑world protocols at this time.
Summary
The paper describes a lab test that can detect extremely diluted antibodies against the sleep‑inducing peptide (DSIP). It shows the test works in a test tube, but it does not provide any information on how to use these ultra‑low‑dose antibodies for health, sleep, or performance.
Abstract
The effects of potentiated homeopathic preparations containing antibodies to delta sleep-inducing peptide in ultralow doses were studied by enzyme immunoassay. Experiments were performed with the following immunochemical reagents: antigens of delta sleep-inducing peptide conjugated to various macromolecular carriers and specific antigens. Antibodies to delta sleep-inducing peptide were synthesized in dilutions of C3, C6, C12, C50, and C200. Enzyme immunoassay showed that test preparations of antibodies in dilutions of 1:400-1:3200 produce the combined effect on immune complex formation. The proposed method holds much promise for identification of medicinal preparations in ultralow doses.
Study Information
pubmed
2003
10.1023/a:1024759503580